NCT04544046

Supportive Oncology Care At Home RCT

Randomized Trial of a Supportive Oncology Care at Home Intervention for Patients With Cancer Receiving Definitive Treatment

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: Massachusetts General Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This research study is evaluating a program that entails remote monitoring and home-based care for people with cancer who are receiving chemotherapy, radiotherapy, or chemoradiotherapy.

Detailed description

Participants receiving treatment for cancer often require multiple care visits and may experience significant symptoms and side-effects related to the cancer and the cancer treatment. This research study is evaluating if a program that involves remote monitoring and home-based care may improve the quality of life, ability to manage symptoms, and overall care of individuals during cancer treatment. Remote monitoring is broadly defined as a way of monitor outside of conventional clinical settings (e.g. in the home) that often utilizes technology to increase access to care. Eligible participants will be randomized into one of two groups: * Usual Care or * Supportive Oncology Care at Home It is expected that about 300 people will take part in this research study.

Conditions

• Pancreatic Cancer
• GastroEsophageal Cancer
• Rectal Cancer
• Head and Neck Cancer
• Lymphoma

Interventions

Type	Name	Description
OTHER	Supportive Oncology Care at Home	Remote monitoring of symptoms, vital signs, and body weight with home-based care to address any concerning issues identified.
OTHER	Usual Care	Standard care arm will receive standard oncology care and attend regular clinic visits.

Timeline

• Start date: 2020-09-16
• Primary completion: 2025-12-31
• Completion: 2025-12-31
• First posted: 2020-09-10
• Last updated: 2025-01-22

Locations

1 site across 1 country: United States